Immunogenicity Rates After SARS-CoV-2 Vaccination in People With End-stage Kidney Disease: A Systema...
Immunogenicity Rates After SARS-CoV-2 Vaccination in People With End-stage Kidney Disease: A Systematic Review and Meta-analysis
About this item
Full title
Author / Creator
Publisher
Chicago: American Medical Association
Journal title
Language
English
Formats
Publication information
Publisher
Chicago: American Medical Association
Subjects
More information
Scope and Contents
Contents
Importance Adults receiving dialysis treatment have a higher likelihood of death when infected with SARS-CoV-2 than adults not receiving dialysis treatment. To date, the immune response of people receiving dialysis after SARS-CoV-2 vaccination has not been systematically discussed. Objective To assess immunogenicity rates in people with end-stage k...
Alternative Titles
Full title
Immunogenicity Rates After SARS-CoV-2 Vaccination in People With End-stage Kidney Disease: A Systematic Review and Meta-analysis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8554642
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8554642
Other Identifiers
ISSN
2574-3805
E-ISSN
2574-3805
DOI
10.1001/jamanetworkopen.2021.31749
